CSIMarket
Company Name or Ticker Symbol
Search for oher Categories
 

Healthcare Sector

Biotechnology & Drugs Industry  


Data by Company within Biotechnology & Drugs Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Avalanche Biotechnologies, Inc. - - $ 0 -
Abbvie Inc. $ 138,192 $ 26,710 $ 6,615 26,000
American Bio Medica Corp $ 4 $ 5 $ -1 -
Acorda Therapeutics Inc $ 1,059 $ 535 $ -43 -
Aclaris Therapeutics, Inc. - - $ 0 -
Actavis Plc - - $ 0 19,200
Ocata Therapeutics, Inc. - - $ 0 -
Adaptimmune Therapeutics Plc $ 4,716 $ 17 $ -76 -
Fennec Pharmaceuticals Inc. - - $ 0 -
Adma Biologics, Inc. $ 55 $ 12 $ -24 -
Adverum Biotechnologies, Inc. $ 148 $ 1 $ 34 -
Aerie Pharmaceuticals Inc $ 2,090 - $ -107 -
Agenus Inc $ 408 $ 41 $ -116 -
Allergan Plc $ 72,068 $ 14,670 $ 11,935 10,500
Applied Genetic Technologies Corp $ 68 $ 47 $ -1 -
Alder Biopharmaceuticals Inc $ 529 - $ -259 -
Alliance Bioenergy Plus, Inc. $ 15 - $ -9 -
Amarillo Biosciences Inc $ 6 - $ -1 -
Amarantus Bioscience Holdings, Inc. - - $ 0 -
Amarantus Bioscience Holdings, Inc. - - $ 0 -
Amgen Inc. $ 137,504 $ 23,050 $ 8,174 17,900
Albany Molecular Research Inc $ 928 $ 681 $ -60 -
Amyris, Inc. $ 78 $ 87 $ -105 440
Aeolus Pharmaceuticals, Inc. $ 10 $ 1 $ -4 -
Ampliphi Biosciences Corp $ 6 $ 0 $ -23 -
Aptevo Therapeutics Inc. $ 43 $ 8 $ -8 -
Ariad Pharmaceuticals Inc - - $ 0 -
Arno Therapeutics, Inc - - $ 0 -
Assembly Biosciences, Inc. $ 534 - $ -51 -
Asterias Biotherapeutics, Inc. $ 158 $ 6 $ -35 -
Atara Biotherapeutics, Inc. $ 453 - $ -97 -
Kubota Pharmaceutical Holdings Co Ltd - - $ 0 -
Aviragen Therapeutics, Inc. $ 28 $ 9 $ -29 -
Anavex Life Sciences Corp. $ 182 $ 0 $ -15 -
Axim Biotechnologies, Inc. $ 267 $ 0 $ -4 -
Axovant Sciences Ltd. $ 2,434 - $ -212 -
Aytu Bioscience, Inc $ 1 $ 3 $ -31 -
Azurrx Biopharma, Inc. $ 43 - $ 0 -
Brainstorm Cell Therapeutics Inc. $ 80 - $ -5 -
Biocryst Pharmaceuticals Inc $ 436 $ 29 $ -47 -
Beesfree, Inc. - - $ 0 -
U.s. Stem Cell, Inc. - $ 4 $ -4 -
Premier Biomedical Inc $ 4 - $ -7 -
Biogen Inc. $ 67,465 $ 11,717 $ 3,288 7,550
Immucor Inc - - $ 0 -
Bluebird Bio, Inc. $ 5,460 $ 27 $ -288 -
Bionovo Inc - - $ 0 -
Audentes Therapeutics, Inc. $ 675 - $ -27 -
Bohai Pharmaceuticals Group, Inc. - - $ 0 -
Biota Pharmaceuticals, Inc. - - $ 0 -
Biopharmx Corp $ 21 $ 0 $ -18 -
Biotech Products Services & Research, Inc. $ 1 $ 0 $ -8 -
Biorestorative Therapies, Inc. $ 17 $ 0 $ -9 -
Boston Therapeutics, Inc. $ 3 $ 0 $ -4 -
Biotime Inc $ 306 $ 4 $ 90 -
Burzynski Research Institute Inc $ 7 - $ -2 -
Cadence Pharmaceuticals Inc - - $ 0 -
General Cannabis Corp $ 40 $ 3 $ -27 -
Capricor Therapeutics, Inc. $ 29 $ 4 $ -17 -
Capstone Therapeutics Corp. $ 3 - $ 1 -
Casi Pharmaceuticals, Inc. $ 61 - $ 4 -
Catalyst Biosciences, Inc. $ 16 $ 1 $ -19 -
Cellular Biomedicine Group, Inc. $ 157 $ 0 $ -29 -
China Botanic Pharmaceutical - - $ 0 -
China Biologic Products Holdings, Inc. $ 2,501 $ 345 $ 128 -
Cellcyte Genetics Corp. - - $ 0 -
Cidara Therapeutics, Inc. $ 117 - $ -57 -
Chromadex Corp. $ 198 $ 20 $ -8 -
Cardax, Inc. $ 41 $ 0 $ -2 -
Cen Biotech Inc - - $ 0 -
Cerecor Inc. $ 10 $ 2 $ -13 -
Compugen Ltd $ 179 - $ 0 -
Coherus Biosciences, Inc. $ 651 $ 178 $ -117 -
Chelsea Therapeutics International, Ltd. - - $ 0 -
China Kangtai Cactus Bio-tech, Inc. - - $ 0 -
Celladon Corporation - - $ 0 -
United Cannabis Corp $ 45 $ 1 $ -4 -
Cannabics Pharmaceuticals Inc. - - $ -1 -
Compass Biotechnologies Inc. - - $ 0 -
Cohbar, Inc. - - $ -8 -
Cocrystal Pharma, Inc. $ 207 - $ -71 -
Cortex Pharmaceuticals Inc - - $ 0 -
Cannapharmarx, Inc. - - $ 0 -
Curis Inc $ 253 $ 8 $ -70 -
Crispr Therapeutics Ag $ 761 - $ 0 -
American Cryostem Corp $ 38 $ 1 $ -1 -
Champions Oncology, Inc. $ 39 $ 17 $ -5 -
Ctd Holdings Inc $ 29 $ 2 $ -4 6
Cellceutix Corp $ 107 - $ -14 -
Cytomx Therapeutics, Inc. $ 644 $ 30 $ -62 -
Citius Pharmaceuticals, Inc. $ 16 - $ -10 1
Neuralstem, Inc. $ 14 $ 0 $ -23 -
Cel Sci Corp $ 14 - $ -10 -
Cv Sciences, Inc. - - $ -11 -
Cyanotech Corp $ 25 $ 34 $ 0 124
Cytodyn Inc. $ 96 - $ -26 -
Cytrx Corp $ 60 - $ -45 -
Dandrit Biotech Usa, Inc. $ 38 - $ -3 -
Diadexus, Inc. - - $ 0 -
Diffusion Pharmaceuticals Inc. $ 24 - $ -16 -
Delmar Pharmaceuticals, Inc. - - $ 0 -
Dimension Therapeutics, Inc. $ 148 $ 15 $ -53 -
Dna Testing Centers Corp - $ 0 $ 0 -
Dendreon Corp - - $ 0 -
Noho, Inc. - - $ 0 -
Windtree Therapeutics Inc - - $ 0 -
Ds Healthcare Group, Inc. $ 0 $ 12 $ -6 105
Emergent Biosolutions Inc. $ 1,896 $ 494 $ 74 -
Edge Therapeutics, Inc. $ 287 - $ -46 -
Eiger Biopharmaceuticals, Inc. $ 97 - $ 0 -
Empowered Products, Inc. - - $ 0 -
Endonovo Therapeutics, Inc. $ 9 - $ -9 -
Entremed Inc - - $ 0 -
Entest Biomedical, Inc. $ 1 - $ 0 -
Enumeral Biomedical Holdings, Inc. $ 1 $ 2 $ -14 -
Enzon Pharmaceuticals, Inc. $ 17 $ 11 $ 1 -
Enzymotec Ltd. - - $ 0 -
Entia Biosciences, Inc. $ 0 $ 0 $ -1 -
Eastgate Biotech Corp - - $ 0 -
Fate Therapeutics Inc $ 176 $ 4 $ -36 -
Fennec Pharmaceuticals Inc. $ 126 - $ -4 -
Fulgent Genetics, Inc. $ 0 $ 10 $ 0 -
Foamix Pharmaceuticals Ltd. $ 210 - $ 0 68
Global Future City Holding Inc. $ 3 $ 3 $ -5 -
Galena Biopharma, Inc. $ 13 - $ -33 -
Gentium S.p.a. - - $ 0 -
Synageva Biopharma Corp - - $ 0 -
Gilead Sciences Inc $ 108,376 $ 27,947 $ 11,097 7,000
Glucose Health, Inc. $ 1 - $ 0 1
Genocea Biosciences, Inc. $ 149 - $ -58 -
Aevi Genomic Medicine, Inc. $ 50 - $ 0 -
Green Planet Bio Engineering Co. Ltd. - - $ 0 -
Green Meadow Products, Inc. $ 161 $ 0 $ 0 -
Guided Therapeutics Inc $ 0 $ 0 $ -3 -
Genethera Inc - - $ 0 -
Gtx Inc $ 129 - $ -26 -
Gtx Corp $ 3 $ 1 $ -1 -
Green Vision Biotechnology Corp. - - $ 0 -
Halozyme Therapeutics Inc. $ 2,241 $ 134 $ -120 -
Hubei Minkang Pharmaceutical Ltd. - - $ 0 -
Health Discovery Corp - - $ 0 -
Hemispherx Biopharma Inc $ 9 $ 0 $ -9 -
Hedgepath Pharmaceuticals, Inc. $ 143 - $ -9 -
Hyperion Therapeutics Inc - - $ 0 -
Heska Corp $ 717 $ 138 $ 15 -
Hst Global, Inc. $ 0 - $ 0 -
Idera Pharmaceuticals, Inc. $ 333 $ 16 $ -49 -
Igi Laboratories, Inc - - $ 0 -
Intelgenx Technologies Corp. $ 47 $ 6 $ -1 -
Intellect Neurosciences, Inc. - - $ 0 -
Immudyne, Inc. $ 23 $ 5 $ -1 11
Immage Biotherapeutics Corp. - - $ 0 -
Immune Therapeutics, Inc. $ 10 - $ -11 -
Integrated Biopharma Inc $ 10 $ 47 $ 3 -
Innovus Pharmaceuticals, Inc. $ 16 $ 8 $ -11 -
Renovacare, Inc. - - $ -3 -
Jounce Therapeutics, inc. $ 363 - $ 0 -
Juno Therapeutics, Inc. $ 4,667 $ 83 $ -293 -
Cadus Corp $ 25 - $ -1 -
Kite Pharma, Inc. $ 10,136 $ 32 $ -359 -
Lion Biotechnologies, Inc. $ 433 - $ -67 -
Lescarden Inc - - $ 0 -
Atyr Pharma Inc $ 92 - $ -52 -
Lixte Biotechnology Holdings, Inc. $ 6 - $ -2 -
La Jolla Pharmaceutical Co $ 726 - $ 0 -
Lightlake Therapeutics Inc. - - $ 0 -
Lazuriton Nano Biotechnology (u.s.a.) Inc. - - $ 0 -
Apollo Endosurgery, inc. - $ 97 $ -52 -
Mateon Therapeutics Inc - - $ 0 -
Mabvax Therapeutics Holdings, Inc. $ 5 - $ -26 -
Multicell Technologies, Inc. - - $ 0 -
Microchannel Technologies Corp - - $ 0 -
Medgenics, Inc. - - $ 0 -
Manhattan Pharmaceuticals Inc - - $ 0 -
Mirna Therapeutics, Inc. $ 36 - $ -28 -
Micromet, Inc. - - $ 0 -
Mj Pharmaceuticals Inc. - - $ 0 -
Momenta Pharmaceuticals Inc $ 1,244 $ 114 $ -45 -
Mount Tam Biotechnologies, Inc. $ 6 - $ -2 -
Marina Biotech, Inc. $ 26 - $ -4 -
Mymetics Corp - $ 1 $ -6 -
Myokardia Inc $ 1,395 $ 43 $ -24 -
Myrexis, Inc. - - $ 0 -
Nascent Biotech Inc. $ 5 - $ 0 -
Neurocrine Biosciences Inc $ 4,992 - $ -220 -
Caladrius Biosciences, Inc. - $ 36 $ 15 -
Northsight Capital, Inc. - $ 0 $ -1 -
Nexus Biopharma Inc - - $ 0 -
Nantkwest, Inc. $ 485 $ 0 $ -104 -
Nile Therapeutics, Inc. - - $ 0 -
Nanoantibiotics, Inc. - - $ 0 -
Nutra Pharma Corp. $ 0 $ 0 $ -4 -
Nanostring Technologies Inc - - $ 0 -
Intellia Therapeutics, Inc. $ 796 $ 23 $ -46 -
Nbty Inc - - $ 0 -
Nugene International, Inc. - - $ 0 8
Nutrastar International Inc. - - $ 0 -
Novavax Inc $ 317 $ 21 $ -212 -
N-viro International Corporation - - $ 0 -
Obalon Therapeutics Inc $ 166 $ 3 $ -15 -
Oncbiomune Pharmaceuticals, Inc $ 12 - $ -4 -
Oncocyte Corp $ 194 - $ 0 -
Spark Therapeutics, Inc. $ 2,565 $ 20 $ -196 -
Oncobiologics, Inc. $ 36 - $ -7 -
Organovo Holdings, Inc. $ 208 $ 4 $ -40 -
Ophthalix, Inc. $ 2 - $ 1 -
Opiant Pharmaceuticals, Inc. $ 56 $ 5 $ 3 -
Avant Diagnostics, Inc. - - $ 0 -
Orgenesis Inc. $ 51,669 $ 11 $ 1 -
Osiris Therapeutics, Inc. - - $ 0 -
Oncovista Innovative Therapies, Inc - - $ 0 -
Mateon Therapeutics Inc - - $ -15 -
Gt Biopharma, Inc. $ 0 - $ -12 -
Prolor Biotech, Inc. - - $ 0 -
Procyon Corporation - $ 4 $ 0 -
Pdl Biopharma, Inc. $ 518 $ 309 $ 131 -
Quint Media Inc. - - $ 0 -
Protokinetix, Inc. $ 13 - $ -2 -
Pulse Biosciences, Inc. $ 200 $ 0 $ -11 -
Protalix Biotherapeutics, Inc. $ 77 $ 11 $ -80 -
Pharmacyte Biotech, Inc. $ 65 - $ -5 -
Proteon Therapeutics Inc $ 29 - $ -26 -
Pluristem Therapeutics Inc $ 137 - $ -28 -
Proteo Inc - $ 0 $ 0 -
Protagonist Therapeutics, Inc $ 279 - $ -22 -
Proteostasis Therapeutics, Inc. $ 47 $ 8 $ -52 -
Pulmatrix, Inc. $ 38 - $ -26 -
Pivot Pharmaceuticals Inc. $ 11 - $ -2 -
Qiagen Nv - - $ 0 -
Quint Media Inc. - - $ 0 -
Rasna Therapeutics Inc. - - $ 0 -
Rich Pharmaceuticals, Inc. $ 0 - $ -3 -
Regenocell Therapeutics, Inc. - - $ 0 -
Receptos, Inc. - - $ 0 -
Ridgefield Acquisition Corp - - $ 0 -
Restorgenex Corp - - $ 0 -
Regen Biopharma Inc $ 6 - $ -6 -
Regado Biosciences Inc - - $ 0 -
Repligen Corp $ 1,616 $ 113 $ 18 -
Regenxbio Inc. $ 914 $ 9 $ -74 -
Regenerx Biopharmaceuticals Inc $ 36 $ 0 $ 2 -
Relmada Therapeutics, Inc. $ 9 - $ -8 -
Repros Therapeutics Inc. $ 9 $ 0 $ -16 -
Respirerx Pharmaceuticals Inc. $ 3 - $ -7 -
Aytu Bioscience, Inc. - - $ 0 -
Ruthigen, Inc. - - $ 0 -
Radient Pharmaceuticals Corp - - $ 0 -
Strongbridge Biopharma Plc $ 253 - $ -80 -
Sangui Biotech International Inc $ 6 $ 0 $ 0 -
Seattle Genetics Inc $ 7,553 $ 429 $ -203 -
Sangamo Therapeutics, Inc $ 1,048 $ 19 $ -72 -
Shengtai Pharmaceutical, Inc. - - $ 0 -
Skinovation Pharmaceutical Inc - - $ 0 -
Skinvisible Inc $ 5 $ 0 $ -2 -
Sun Biopharma, Inc. $ 37 - $ -10 -
Syndax Pharmaceuticals Inc $ 231 $ 1 $ -50 -
Soligenix, Inc. $ 13 $ 7 $ -6 -
Senesco Technologies Inc - - $ 0 -
Senesco Technologies Inc - - $ 0 -
Microbot Medical Inc. - - $ -7 -
Sunwin Stevia International, Inc. - - $ 0 -
Intellicell Biosciences, Inc. - - $ 0 -
Savient Pharmaceuticals Inc - - $ 0 -
Sevion Therapeutics, Inc. $ 6 - $ -5 -
Tobira Therapeutics, Inc. - - $ 0 -
Tracon Pharmaceuticals, Inc. $ 62 $ 3 $ -26 -
Bio-techne Corp $ 4,571 $ 563 $ 76 -
Telik Inc - - $ 0 -
Mabvax Therapeutics Holdings, Inc. - - $ 0 -
Tongli Pharmaceuticals (usa), Inc. - - $ 0 -
Tg Therapeutics, Inc. $ 744 $ 0 $ -105 -
Tg Therapeutics, Inc. - - $ 0 -
Twinlab Consolidated Holdings, Inc. $ 233 $ 89 $ 0 -
Teligent, Inc. $ 368 $ 72 $ -8 -
Targeted Medical Pharma, Inc. - - $ 0 -
Targacept Inc - - $ 0 -
Trovagene, Inc. $ 22 $ 0 $ -37 -
Therapeutic Solutions International, Inc. $ 9 $ 0 $ -1 -
Trius Therapeutics Inc - - $ 0 -
Taxus Pharmaceuticals Holdings, Inc. - - $ 0 -
Tyme Technologies, Inc. $ 340 - $ -15 -
Uluru Inc. $ 4 $ 0 $ -4 -
United Bancshares Inc - - $ 0 -
Vitality Biopharma, Inc. $ 34 $ 0 $ -1 -
Vericel Corp $ 159 $ 54 $ -25 -
Vical Inc $ 27 $ 12 $ -11 -
Viropharma Inc - - $ 0 -
Vistagen Therapeutics, Inc. - - $ -10 -
Vistagen Therapeutics, Inc. - - $ 0 -
Ventrus Biosciences Inc - - $ 0 -
Voyager Therapeutics, Inc. $ 450 $ 8 $ 21 -
Warner Chilcott Plc - - $ 0 -
Windtree Therapeutics Inc $ 2 $ 1 $ -5 -
Weikang Bio-technology Group Co., Inc. - - $ 0 -
Wave Life Sciences Ltd. $ 566 $ 2 $ -69 -
Xenetic Biosciences, Inc. $ 23 - $ -13 -
Acceleron Pharma Inc $ 1,521 $ 13 $ -95 -
Xstelos Holdings, Inc. - - $ 0 -
Biotechnology & Drugs Industry $ 661,274 $ 109,342 $ 35,751 88,914
Earnings Earnings Earnings
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates.
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry.
Earnings Estimates decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %.
Expected Eps Growth Eps Expectation Revision
n   %     Industry Expected EPS Growth
Total Ranking # Within Sector #
n   %   Industry Earnings Outlook Revision
Total Ranking # Within Sector #
Revenue Revenue Revenue
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year.
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year.
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases
Expected Revenue Growth Revenue Expectation Revision
  %     Industry Expected Revenue Growth
Total Ranking # Within Sector #
  %   Industry Revenue Outlook Revision
Total Ranking # Within Sector #





Cardiovascular Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
24.1% -16.78% 377.7% -84.61%
Y/Y Q/Q Y/Y Q/Q

Economy

Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks

Event Calendar

AVGO's Report

AVGO's News

AVGO's Revenue Growth

AVGO's Description

Fundamentals

Charts & Quotes

AVGO's ROI

Suppliers

Competition

Customers & Markets

AVGO's Profitability

AVGO's Growth

Segment Results

AVGO's PE

AVGO's Dividends

AVGO's Quick Ratio

Screening


Share Price Performance

Growth Rates Ranking

Profitability

Valuation

Dividend

Financial Strength

Efficiency Ranking

Expectations

Mgmnt. Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com